BioLabs France

🔁 Huge congratulations to Eukarÿs SAS on winning Sanofi’s Golden Ticket 2024! 🎉 We’re thrilled to support their innovative work in advancing bioproduction yields and proud to foster such groundbreaking innovation at BioLabs France Hôtel-Dieu.

🚀 Take Your Life Science Startup to the Next Level! 🚀 📅 Save the Date: November 26, 2024, at 11:00 AM CET Join us for an inspiring webinar to discover how the collaboration between Novo Nordisk and BioLabs is fostering breakthrough innovations in Type 2 Diabetes (T2D), Obesity, and Cardiovascular Diseases (CVD). Accelerate your R&D activities and join an exclusive innovation ecosystem! Whether it’s access to cutting-edge lab space, world-class mentorship, or a thriving network of life science innovators, the opportunities are endless. 🌟 🎯 Don’t miss out! At the end of the webinar, we’ll officially launch our new Golden Ticket Campaign, giving you the chance to apply for a one-year residency at either BioLabs France Heidelberg or BioLabs Hôtel-Dieu. Be the first to access this unique opportunity to work in Europe’s most dynamic life science hubs! 🔗 Register now: https://lnkd.in/eY-SUQ4E We can’t wait to connect with you and share how we’re committed to driving high-impact innovation in life sciences. 💡 #Innovation #LifeSciences #BioLabs #NovoNordisk #GoldenTicket #Biotech Daniel Timmermann Itai Kela, PhD, MBA Miriam Frieden Neil Anderson Joerg D. Hoeck, Ph.D. Tomas Landh Bill Haynes Johanna Michielin Ann-Kristin Mueller Christophe Tallec

Launching a successful biotech startup demands relentless drive, bold ideas, and the right ecosystem to thrive. 🚀✨ The Servier Golden Ticket at #Spartners by Servier and BioLabs, offers exactly that—and so much more! With a #FREE one-year residency at Spartners, you’ll get: 👥 The right support to thrive (guessed it, haven't you?) 🌟 Your own dedicated space in a vibrant, trailblazing biotech community 🔬 Access to cutting-edge facilities and specialized equipment that accelerate your innovation 🤝 BioLabs’ experienced, on-site staff who manages daily facility operations, and allowing scientists to focus on science! 🤝 Bespoke mentorship from Servier's top industry leaders ready to supercharge your journey And there’s more—non-finalists will still receive expert-led pitch training to hone your skills, refine your strategy, and propel your startup's growth. Join a community shaping the future of biotech. 🚀 Applications close on December 1st ⌛️ Apply here 👉 https://lnkd.in/eJPwvxSN Johanna Michielin, Hélène Sire, Margaux Lesbats, Anais Ralimbimanana, Jean-Roch Llense, Marianna Karampournioti Sotti, Chaimaa Asri, Celine Triquel, Nadia Benallal, Laura Dupuy

🚨 Exciting Opportunity Alert for Medical Biotech Startups! 🚨 We are thrilled to announce the launch of our Startup Program in collaboration with Hello Tomorrow and Digital Medical Hub. If you're working in biotech, techbio, or medtech and looking to accelerate your journey from lab to market, this program is designed for you. 🧪💡 Don't miss this chance to elevate your startup with great mentorship and vital industry connections! Apply by December 19th to secure your spot. 👉 Learn more and apply: https://lnkd.in/eAW3UaK3 #Biotech #Medtech #Startups #HelloTomorrow #Innovation #HealthcareTransformation #BioLabsFrance

🧬 Calling all health-focused startups! 🧬 If you’re looking to accelerate your solution, this is your opportunity! The Spartners incubator, powered by Servier and BioLabs France, is a unique opportunity to fast-track your innovation within the dynamic Paris-Saclay ecosystem. 🔔 Apply for a chance to: → Access state-of-the-art labs and equipment → Connect with a global network of healthcare and innovation experts. → Win an exclusive “Golden Ticket” granting you free access to the incubator for one year. 🗓 Next key dates to note: → Ask Me Anything webinar on November 18th at 4PM (CET) to answer all your questions directly from Servier and BioLabs teams! 👉 https://bit.ly/3YATTWi → Apply before December 29th 2024: https://bit.ly/4ehjxoW #StartupCall #HealthInnovation #Biotech #LifeSciences #Servier #BioLabs #ParisSaclay #Spartners #Incubator

🎉 Throwback to an Engaging Breakfast & Learn Session with ChemoMetec! 🎉 Last Thursday, we had the pleasure of hosting an insightful session at BioLabs Hôtel-Dieu, presented by our General Sponsor ChemoMetec. Participants explored the innovative NucleoCounter® NC-202™, a tool designed to accelerate research across a variety of cell types, including PBMCs, mammalian cells, yeast, insect cells, and more. 🧪✨ A special thank you to Samer Masri, PhD Field Application Scientist at ChemoMetec, for sharing his expertise and leading hands-on demos in the afternoon. 🙌 It was a great opportunity to connect with the community, learn about cutting-edge solutions, and discover how ChemoMetec’s technologies are transforming research. 🚀 Stay tuned for more exciting events at BioLabs Hôtel-Dieu! #BioLabs #ChemoMetec #CellCounting #Biotech #Innovation #ResearchTools Christophe Tallec, Clément Lapierre, Paulina Ejsmont, Anushree Kumar, Margaux Lesbats, Alessandro Ancillotti Christopher Hastrup

🌐 We are SOLD OUT for the next Apéro Innovation @Hôtel-Dieu! 🌐 This month, the Paris Bits in Bio chapter, co-organized by BioLabs Hôtel-Dieu, Orakl Oncology, and Speedinvest, will dive into the challenges of AI projects in the hospital environment. This session features insights from: Pascaline Safar - Villié, Operation Manager at Bernoulli Lab Ninon Burgos, Researcher at CNRS Gain fresh perspectives at the intersection of biology, AI, and scientific innovation, followed by a networking drink at BioLabs Hôtel-Dieu. 🥂 Follow us if you want to participate to the next Bits in Bio and Apéro Innovation ! #ApéroInnovation #BioLabs #BitsinBio #AIinHealthcare #BiotechCommunity #Networking

#Throwback to our event on Genome Edition (November 13th, 2024) 🌟 As part of our Paris-Saclay Life Science Talks, we gathered leading experts at #Spartners to explore the transformative potential of genome edition in healthcare. From discussions on CRISPR-based therapies like Casgevy for sickle cell and beta thalassemia diseases to innovative DNA editing alternatives, the dialogue showcased both groundbreaking promise and ethical responsibilities. A heartfelt thank you to our incredible speakers and moderator who made this event truly impactful:  👤 Helene Virasith, – who skillfully moderated the conversation, providing essential context on genome edition techniques and ensuring a meaningful, engaging discussion throughout the event.  🔹 Pr Pablo Bartolucci MD PhD, who shared valuable clinical insights on CRISPR-based therapies and their transformative potential for patient care.  🔹 Frédéric ZAMPATTI, who introduced us to innovative alternative DNA editing techniques, offering a glimpse into new possibilities for gene therapy.  🔹 Emmanuelle Billon-Denis, who led an important exploration of the ethical, biological, and security considerations tied to genome editing technologies. 🚨 Don’t miss our next event organized by La the BioTeam: Next-Generation Antibodies! Find all the details and register here: 🔗 https://lnkd.in/eXubzjBq. Johanna Michielin, Hélène Sire, Margaux Lesbats, Anais Ralimbimanana, Chaimaa Asri, Celine Triquel, Nadia Benallal, Laura Dupuy

Get the inside scoop on how biotech is changing health with next-gen antibodies – featuring top minds from industry and academia! 🚀🧫 📅 Date: December 2nd, 2024 🕛 Time: 12:00 PM - 2:00 PM 📍 Location: Lumen – 8 Av. des Sciences, 91190 Gif-sur-Yvette Join us for a groundbreaking exploration into the future of antibodies, where startups, industrial leaders and academic pioneers unite to reshape human health! Panelists you don’t want to miss: 🌟 ▶ Emilia McLaughlin, CEO of kyron.bio – Turning the tide in cancer and autoimmune diseases with innovative antibody therapies. ▶ Claus Haase, SVP at Symphogen A/S (a Servier company) – Driving industry-led advancements in next-gen antibody development. ▶ Bernard Maillere, Director of Research in Immunology, Université Paris-Saclay – Accelerating antibody innovation with deep academic expertise. 🎤 Moderated by: Estefania Tumbaco Valarezo, PhD student in Immunotoxicology at Servier and Université Paris-Saclay, bringing her expertise and unique perspective to guide this impactful discussion 🚀 Powered by #LaBioTeam: Your ultimate catalyst for biotech success, made up of: ✨ Genopole – Facilitating and accelerating the creation and development of life science companies. ⚡ #Spartners – Accelerating time-to-market for biotech companies  🔬 IncubAlliance Paris-Saclay – Public incubator for deeptech entrepreneurs. 🏗️ Kadans Science Partner – Built for innovation. 💬 What’s in it for you? Connect with industry leaders, spark ideas with cutting-edge insights, and level up your network like never before! Register now 🔗 https://lnkd.in/eXubzjBq Johanna Michielin, Hélène Sire, Margaux Lesbats, Anais Ralimbimanana, Chaimaa Asri, Celine Triquel, Laura Dupuy, Nadia Benallal, Arielle Santé, Elise Colla, Helene Virasith, Stéphanie TEA

🔍 Discover the resources you need to bring your life science startup to life and intensify your R&D activities! The opportunities are endless, whether you're seeking laboratory space, mentorship, or access to an exclusive innovation ecosystem. 🗓 🕐 Mark your calendars for 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟮𝟲, 𝟮𝟬𝟮𝟰, 𝗮𝘁 𝟭𝟭 𝗔𝗠 𝗖𝗘𝗧 and join us for an inspiring webinar where you'll learn more about the collaboration between Novo Nordisk and BioLabs in Europe and how you can take advantage of these opportunities to work on the next scientific breakthrough in the fields of 𝗧𝘆𝗽𝗲 𝟮𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 (𝗧𝟮𝗗), 𝗢𝗯𝗲𝘀𝗶𝘁𝘆, 𝗮𝗻𝗱 𝗖𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀 (𝗖𝗩𝗗).  We can’t wait to meet you and give you more insights on how we are committed to accelerating high-impact innovation wherever it originates. By launching our new Golden Ticket Campaign at the end of our webinar, you will get first-hand information and early access to apply for a one-year residency at BioLabs France Heidelberg or BioLabs Hotel-Dieu (BioLabs France) to have the chance to join one of the two growing life science hubs in Europe.  Register today - https://lnkd.in/eY-SUQ4E Daniel Timmermann Itai Kela, PhD, MBA Miriam Frieden Neil Anderson Joerg D. Hoeck, Ph.D. Tomas Landh Bill Haynes Johanna Michielin Ann-Kristin Mueller Christophe Tallec